PANACEABIO Q1 FY27 results at a glance
PANACEA BIOTEC LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹200 cr |
|---|
| Revenue YoY | +19.7% |
|---|
| Operating profit | -₹2.23 cr |
|---|
| Operating margin | -1.1% |
|---|
| Net profit | ₹2.3 cr |
|---|
| Net profit YoY | -43.2% |
|---|
| Net profit QoQ | +342.3% |
|---|
| Net margin | 1.2% |
|---|
| Basic EPS | ₹0.38 |
|---|
| TTM revenue | ₹673 cr |
|---|
| TTM net profit | -₹7.12 cr |
|---|
| TTM net margin | -1.1% |
|---|
PANACEABIO Q1 FY27 results: what the numbers say
PANACEA BIOTEC LTD (PANACEABIO) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹200 cr and a net profit of ₹2.3 cr, translating into earnings per share of ₹0.38.
Compared with the same quarter a year earlier, revenue grew by +19.7% and net profit declined strongly by -43.2%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at -₹2.23 cr, an operating margin of -1.1% versus -5.7% a year ago — a gain of 4.6 percentage points.
PANACEABIO quarter-wise results table
Net profit
₹2.3 cr
-43.2% YoY
Operating profit
-₹2.23 cr
+76.7% YoY
PANACEA BIOTEC LTD (PANACEABIO) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹200 cr | -₹2.23 cr | ₹2.3 cr | -1.1% | 1.2% | ₹0.38 | -43.2% | +342.3% |
| Q4 FY262026-03-31 | ₹167 cr | -₹5.31 cr | ₹0.52 cr | -3.2% | 0.3% | ₹0.08 | — | -86.9% |
| Q3 FY262025-12-31 | ₹165 cr | ₹3.29 cr | ₹3.98 cr | 2.0% | 2.4% | ₹0.65 | — | +128.6% |
| Q2 FY262025-09-30 | ₹141 cr | -₹26.13 cr | -₹13.92 cr | -18.5% | -9.9% | ₹-2.27 | — | -443.7% |
| Q1 FY262025-06-30 | ₹167 cr | -₹9.57 cr | ₹4.05 cr | -5.7% | 2.4% | ₹0.66 | — | — |
| TTM (last 4 quarters) | ₹673 cr | -₹30.38 cr | -₹7.12 cr | -4.5% | -1.1% | ₹-1.16 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
PANACEABIO quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
PANACEA BIOTEC LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹200 cr | ₹167 cr | ₹165 cr | ₹141 cr | ₹167 cr |
|---|
| Total expenses | ₹202 cr | ₹172 cr | ₹162 cr | ₹167 cr | ₹176 cr |
|---|
| Gross profit | ₹97.86 cr | ₹90.36 cr | ₹97.26 cr | ₹82.19 cr | ₹89.48 cr |
|---|
| Operating profit (EBIT) | -₹2.23 cr | -₹5.31 cr | ₹3.29 cr | -₹26.13 cr | -₹9.57 cr |
|---|
| Operating margin | -1.1% | -3.2% | 2.0% | -18.5% | -5.7% |
|---|
| Interest cost | ₹1.18 cr | ₹1.2 cr | ₹1.85 cr | ₹2.14 cr | ₹0.86 cr |
|---|
| Profit before tax | ₹3.57 cr | -₹1.25 cr | ₹6.49 cr | -₹19.17 cr | ₹6.56 cr |
|---|
| Tax expense | ₹1.37 cr | -₹0.25 cr | ₹2.6 cr | -₹5.16 cr | ₹2.6 cr |
|---|
| Effective tax rate | 38.4% | 20.0% | 40.1% | 26.9% | 39.6% |
|---|
| Net profit (PAT) | ₹2.3 cr | ₹0.52 cr | ₹3.98 cr | -₹13.92 cr | ₹4.05 cr |
|---|
| Net profit margin | 1.2% | 0.3% | 2.4% | -9.9% | 2.4% |
|---|
| Basic EPS | ₹0.38 | ₹0.08 | ₹0.65 | ₹-2.27 | ₹0.66 |
|---|
| Diluted EPS | ₹0.38 | ₹0.08 | ₹0.65 | ₹-2.27 | ₹0.66 |
|---|
PANACEABIO results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +19.7% | — | — | — | — |
|---|
| Revenue QoQ | +19.7% | +0.9% | +17.0% | -15.3% | — |
|---|
| Operating profit YoY | +76.7% | — | — | — | — |
|---|
| Operating profit QoQ | +58.0% | -261.4% | +112.6% | -173.0% | — |
|---|
| Net profit YoY | -43.2% | — | — | — | — |
|---|
| Net profit QoQ | +342.3% | -86.9% | +128.6% | -443.7% | — |
|---|
| EPS YoY | -42.4% | — | — | — | — |
|---|
| EPS QoQ | +375.0% | -87.7% | +128.6% | -443.9% | — |
|---|
PANACEABIO annual results history
Full-year performance for PANACEA BIOTEC LTD, useful for reading each quarter in context.
PANACEA BIOTEC LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹640 cr | ₹559 cr | ₹552 cr | ₹457 cr |
|---|
| Total expenses | ₹677 cr | ₹620 cr | ₹596 cr | ₹563 cr |
|---|
| Gross profit | ₹359 cr | ₹360 cr | ₹283 cr | ₹178 cr |
|---|
| Operating profit (EBIT) | -₹37.72 cr | -₹60.72 cr | -₹44.22 cr | -₹106 cr |
|---|
| Operating margin | -5.9% | -10.9% | -8.0% | -23.1% |
|---|
| Interest cost | ₹6.05 cr | ₹3.88 cr | ₹2.67 cr | ₹3.8 cr |
|---|
| Profit before tax | -₹7.37 cr | -₹7.95 cr | ₹1.48 cr | ₹12.81 cr |
|---|
| Tax expense | -₹0.21 cr | ₹0.77 cr | ₹2.98 cr | ₹46.55 cr |
|---|
| Effective tax rate | 2.8% | -9.7% | 201.9% | 363.5% |
|---|
| Net profit (PAT) | -₹5.37 cr | -₹8.37 cr | -₹1.17 cr | -₹33.24 cr |
|---|
| Net profit margin | -0.8% | -1.5% | -0.2% | -7.3% |
|---|
| Basic EPS | ₹-0.88 | ₹-1.37 | ₹-0.19 | ₹-5.43 |
|---|
| Diluted EPS | ₹-0.88 | ₹-1.37 | ₹-0.19 | ₹-5.43 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹200 cr against ₹167 cr in Q1 FY26, and ₹167 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +19.7%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹202 cr, or 101.1% of revenue, with operating profit grew +76.7% year on year.
Margins, tax and profitability
Net profit of ₹2.3 cr works out to a net margin of 1.2% compared with 2.4% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, PANACEA BIOTEC LTD reported profit before tax of ₹3.57 cr, a tax charge of ₹1.37 cr (effective rate 38.4%), interest cost of ₹1.18 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹0.52 cr in Q4 FY26 to ₹2.3 cr in Q1 FY27, a change of +342.3%.
Trailing twelve months and annual context
Across the trailing four quarters PANACEA BIOTEC LTD has generated revenue of ₹673 cr and net profit of -₹7.12 cr, a trailing net margin of -1.1%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹640 cr with net profit of -₹5.37 cr and EPS of ₹-0.88, versus the prior year where revenue grew +14.4% and profit grew +35.8%.
What to watch in the next PANACEABIO quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
PANACEA BIOTEC LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
PANACEABIO results coverage
No results report published for PANACEABIO yet — our desk covers each quarter within minutes of the filing.
PANACEABIO quarterly results FAQs
What were PANACEA BIOTEC LTD (PANACEABIO) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), PANACEA BIOTEC LTD reported revenue of ₹200 cr and net profit of ₹2.3 cr, a change of -43.2% year on year on +19.7% revenue growth. EPS stood at ₹0.38.
What is PANACEABIO profit margin in Q1 FY27?
PANACEA BIOTEC LTD posted a net profit margin of 1.2% and an operating margin of -1.1% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹673 cr and net profit -₹7.12 cr.
Did PANACEABIO results beat the previous quarter?
PANACEA BIOTEC LTD net profit changed +342.3% quarter on quarter, from ₹0.52 cr in Q4 FY26 to ₹2.3 cr in Q1 FY27.
When are PANACEA BIOTEC LTD (PANACEABIO) quarterly results?
PANACEA BIOTEC LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see PANACEABIO latest quarterly results?
Results coverage for PANACEABIO will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the PANACEABIO stock page.
What is PANACEA BIOTEC LTD annual revenue and profit?
For FY26, PANACEA BIOTEC LTD reported full-year revenue of ₹640 cr and net profit of -₹5.37 cr, with EPS of ₹-0.88.
How many quarterly results has PANACEABIO declared recently?
Past results dates for PANACEABIO will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
